Bausch Health price target raised to $41 from $39 at Mizuho

Mizuho analyst Irina Koffler raised her price target for Bausch Health Companies to $41 from $39 following the company’s Q4 results and a meeting with management. Most companies struggle to attain long-term guidance targets, but Bausch’s 2019-2022 outlook is “within reach,” Koffler tells investors in a research note. She reiterates a Buy rating on the shares.

https://thefly.com/landingPageNews.php?id=2880283